nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—Vinca Alkaloids—Vincristine—hematologic cancer	0.151	0.5	CiPCiCtD
Vinorelbine—Vinca Alkaloids—Vinblastine—hematologic cancer	0.151	0.5	CiPCiCtD
Vinorelbine—Vinblastine—hematologic cancer	0.114	0.5	CrCtD
Vinorelbine—Vincristine—hematologic cancer	0.114	0.5	CrCtD
Vinorelbine—TUBB2A—hematologic cancer	0.0905	0.902	CbGaD
Vinorelbine—Vinblastine—Vincristine—hematologic cancer	0.0267	0.189	CrCrCtD
Vinorelbine—Vincristine—Vinblastine—hematologic cancer	0.0267	0.189	CrCrCtD
Vinorelbine—Vindesine—Vinblastine—hematologic cancer	0.0267	0.189	CrCrCtD
Vinorelbine—Vindesine—Vincristine—hematologic cancer	0.0267	0.189	CrCrCtD
Vinorelbine—Voacamine—Vincristine—hematologic cancer	0.0171	0.121	CrCrCtD
Vinorelbine—Voacamine—Vinblastine—hematologic cancer	0.0171	0.121	CrCrCtD
Vinorelbine—ABCB1—hematologic cancer	0.00986	0.0983	CbGaD
Vinorelbine—TUBB6—Vinblastine—hematologic cancer	0.00682	0.0473	CbGbCtD
Vinorelbine—TUBB3—Vinblastine—hematologic cancer	0.00682	0.0473	CbGbCtD
Vinorelbine—TUBB2B—Vinblastine—hematologic cancer	0.00682	0.0473	CbGbCtD
Vinorelbine—TUBB4A—Vinblastine—hematologic cancer	0.00682	0.0473	CbGbCtD
Vinorelbine—TUBB8—Vinblastine—hematologic cancer	0.00682	0.0473	CbGbCtD
Vinorelbine—TUBB2A—Vinblastine—hematologic cancer	0.00682	0.0473	CbGbCtD
Vinorelbine—TUBB3—Vincristine—hematologic cancer	0.00671	0.0465	CbGbCtD
Vinorelbine—TUBB8—Vincristine—hematologic cancer	0.00671	0.0465	CbGbCtD
Vinorelbine—TUBB2B—Vincristine—hematologic cancer	0.00671	0.0465	CbGbCtD
Vinorelbine—TUBB2A—Vincristine—hematologic cancer	0.00671	0.0465	CbGbCtD
Vinorelbine—TUBB6—Vincristine—hematologic cancer	0.00671	0.0465	CbGbCtD
Vinorelbine—TUBB4A—Vincristine—hematologic cancer	0.00671	0.0465	CbGbCtD
Vinorelbine—TUBB—Vinblastine—hematologic cancer	0.00571	0.0395	CbGbCtD
Vinorelbine—TUBB1—Vinblastine—hematologic cancer	0.00571	0.0395	CbGbCtD
Vinorelbine—TUBB4B—Vinblastine—hematologic cancer	0.00571	0.0395	CbGbCtD
Vinorelbine—TUBB4B—Vincristine—hematologic cancer	0.00561	0.0389	CbGbCtD
Vinorelbine—TUBB1—Vincristine—hematologic cancer	0.00561	0.0389	CbGbCtD
Vinorelbine—TUBB—Vincristine—hematologic cancer	0.00561	0.0389	CbGbCtD
Vinorelbine—ABCB1—Lenalidomide—hematologic cancer	0.00163	0.0113	CbGbCtD
Vinorelbine—CYP2D6—Lomustine—hematologic cancer	0.00143	0.00989	CbGbCtD
Vinorelbine—CYP2D6—Idarubicin—hematologic cancer	0.00127	0.00881	CbGbCtD
Vinorelbine—CYP2D6—Hydroxyurea—hematologic cancer	0.00108	0.00749	CbGbCtD
Vinorelbine—CYP3A4—Bexarotene—hematologic cancer	0.000976	0.00676	CbGbCtD
Vinorelbine—ABCB1—Daunorubicin—hematologic cancer	0.000955	0.00662	CbGbCtD
Vinorelbine—CYP2D6—Bortezomib—hematologic cancer	0.000941	0.00652	CbGbCtD
Vinorelbine—ABCB1—Alitretinoin—hematologic cancer	0.000936	0.00648	CbGbCtD
Vinorelbine—CYP3A4—Lomustine—hematologic cancer	0.000908	0.00629	CbGbCtD
Vinorelbine—CYP3A4—Busulfan—hematologic cancer	0.000908	0.00629	CbGbCtD
Vinorelbine—CYP3A4—Thiotepa—hematologic cancer	0.000809	0.0056	CbGbCtD
Vinorelbine—ABCB1—Imatinib—hematologic cancer	0.000732	0.00507	CbGbCtD
Vinorelbine—CYP2D6—Imatinib—hematologic cancer	0.000689	0.00478	CbGbCtD
Vinorelbine—ABCB1—Nilotinib—hematologic cancer	0.000665	0.00461	CbGbCtD
Vinorelbine—CYP3A4—Methoxsalen—hematologic cancer	0.000629	0.00436	CbGbCtD
Vinorelbine—CYP2D6—Nilotinib—hematologic cancer	0.000626	0.00434	CbGbCtD
Vinorelbine—CYP3A4—Bortezomib—hematologic cancer	0.000598	0.00414	CbGbCtD
Vinorelbine—ABCB1—Dasatinib—hematologic cancer	0.000588	0.00407	CbGbCtD
Vinorelbine—ABCB1—Mitoxantrone—hematologic cancer	0.00058	0.00402	CbGbCtD
Vinorelbine—CYP3A4—Daunorubicin—hematologic cancer	0.000572	0.00396	CbGbCtD
Vinorelbine—TUBB3—hematopoietic system—hematologic cancer	0.000542	0.0503	CbGeAlD
Vinorelbine—TUBB1—hematopoietic system—hematologic cancer	0.000529	0.0492	CbGeAlD
Vinorelbine—ABCB1—Betamethasone—hematologic cancer	0.000517	0.00358	CbGbCtD
Vinorelbine—ABCB1—Gemcitabine—hematologic cancer	0.000513	0.00355	CbGbCtD
Vinorelbine—ABCB1—Prednisolone—hematologic cancer	0.00051	0.00354	CbGbCtD
Vinorelbine—CYP3A4—Cytarabine—hematologic cancer	0.000505	0.0035	CbGbCtD
Vinorelbine—CYP3A4—Teniposide—hematologic cancer	0.000497	0.00344	CbGbCtD
Vinorelbine—ABCB1—Prednisone—hematologic cancer	0.000482	0.00334	CbGbCtD
Vinorelbine—CYP3A4—Ifosfamide—hematologic cancer	0.000459	0.00318	CbGbCtD
Vinorelbine—ABCB1—Irinotecan—hematologic cancer	0.000457	0.00317	CbGbCtD
Vinorelbine—CYP3A4—Imatinib—hematologic cancer	0.000438	0.00304	CbGbCtD
Vinorelbine—TUBB8—testis—hematologic cancer	0.000435	0.0404	CbGeAlD
Vinorelbine—CYP3A4—Ruxolitinib—hematologic cancer	0.000413	0.00286	CbGbCtD
Vinorelbine—ABCB1—Vinblastine—hematologic cancer	0.000406	0.00281	CbGbCtD
Vinorelbine—ABCB1—Vincristine—hematologic cancer	0.000399	0.00277	CbGbCtD
Vinorelbine—CYP3A4—Nilotinib—hematologic cancer	0.000398	0.00276	CbGbCtD
Vinorelbine—CYP2D6—Vinblastine—hematologic cancer	0.000383	0.00265	CbGbCtD
Vinorelbine—ABCB1—Cisplatin—hematologic cancer	0.000373	0.00258	CbGbCtD
Vinorelbine—ABCB1—Etoposide—hematologic cancer	0.000366	0.00254	CbGbCtD
Vinorelbine—CYP3A4—Triamcinolone—hematologic cancer	0.000361	0.0025	CbGbCtD
Vinorelbine—TUBB3—blood—hematologic cancer	0.000359	0.0333	CbGeAlD
Vinorelbine—CYP3A4—Dasatinib—hematologic cancer	0.000352	0.00244	CbGbCtD
Vinorelbine—TUBB1—blood—hematologic cancer	0.000351	0.0326	CbGeAlD
Vinorelbine—CYP3A4—Mitoxantrone—hematologic cancer	0.000348	0.00241	CbGbCtD
Vinorelbine—TUBB1—bone marrow—hematologic cancer	0.000339	0.0315	CbGeAlD
Vinorelbine—TUBB4A—hematopoietic system—hematologic cancer	0.00033	0.0306	CbGeAlD
Vinorelbine—TUBB3—lung—hematologic cancer	0.000315	0.0292	CbGeAlD
Vinorelbine—CYP3A4—Betamethasone—hematologic cancer	0.00031	0.00215	CbGbCtD
Vinorelbine—CYP3A4—Prednisolone—hematologic cancer	0.000306	0.00212	CbGbCtD
Vinorelbine—ABCB1—Dexamethasone—hematologic cancer	0.000301	0.00208	CbGbCtD
Vinorelbine—TUBB2A—hematopoietic system—hematologic cancer	0.0003	0.0278	CbGeAlD
Vinorelbine—TUBB3—testis—hematologic cancer	0.000297	0.0275	CbGeAlD
Vinorelbine—TUBB6—hematopoietic system—hematologic cancer	0.000296	0.0274	CbGeAlD
Vinorelbine—TUBB1—testis—hematologic cancer	0.00029	0.0269	CbGeAlD
Vinorelbine—CYP3A4—Prednisone—hematologic cancer	0.000289	0.002	CbGbCtD
Vinorelbine—CYP2D6—Dexamethasone—hematologic cancer	0.000284	0.00196	CbGbCtD
Vinorelbine—CYP3A4—Irinotecan—hematologic cancer	0.000274	0.0019	CbGbCtD
Vinorelbine—TUBB4B—hematopoietic system—hematologic cancer	0.000257	0.0239	CbGeAlD
Vinorelbine—TUBB4A—gonad—hematologic cancer	0.000251	0.0233	CbGeAlD
Vinorelbine—ABCB1—Doxorubicin—hematologic cancer	0.00025	0.00173	CbGbCtD
Vinorelbine—CYP3A4—Vinblastine—hematologic cancer	0.000243	0.00169	CbGbCtD
Vinorelbine—TUBB2B—gonad—hematologic cancer	0.000242	0.0225	CbGeAlD
Vinorelbine—ABCB1—Methotrexate—hematologic cancer	0.000242	0.00168	CbGbCtD
Vinorelbine—CYP3A4—Vincristine—hematologic cancer	0.000239	0.00166	CbGbCtD
Vinorelbine—CYP2D6—Doxorubicin—hematologic cancer	0.000235	0.00163	CbGbCtD
Vinorelbine—TUBB6—gonad—hematologic cancer	0.000225	0.0209	CbGeAlD
Vinorelbine—CYP3A4—Etoposide—hematologic cancer	0.000219	0.00152	CbGbCtD
Vinorelbine—TUBB4A—blood—hematologic cancer	0.000218	0.0203	CbGeAlD
Vinorelbine—Vinblastine—TUBB2A—hematologic cancer	0.000214	0.246	CrCbGaD
Vinorelbine—Vincristine—TUBB2A—hematologic cancer	0.00021	0.241	CrCbGaD
Vinorelbine—TUBB—blood—hematologic cancer	0.0002	0.0185	CbGeAlD
Vinorelbine—TUBB2A—blood—hematologic cancer	0.000199	0.0184	CbGeAlD
Vinorelbine—TUBB6—blood—hematologic cancer	0.000196	0.0182	CbGeAlD
Vinorelbine—TUBB4B—gonad—hematologic cancer	0.000195	0.0181	CbGeAlD
Vinorelbine—TUBB—bone marrow—hematologic cancer	0.000193	0.0179	CbGeAlD
Vinorelbine—TUBB2A—bone marrow—hematologic cancer	0.000192	0.0178	CbGeAlD
Vinorelbine—TUBB4A—lung—hematologic cancer	0.000191	0.0178	CbGeAlD
Vinorelbine—TUBB6—bone marrow—hematologic cancer	0.00019	0.0176	CbGeAlD
Vinorelbine—TUBB2B—lung—hematologic cancer	0.000185	0.0172	CbGeAlD
Vinorelbine—TUBB4A—testis—hematologic cancer	0.000181	0.0168	CbGeAlD
Vinorelbine—CYP3A4—Dexamethasone—hematologic cancer	0.00018	0.00125	CbGbCtD
Vinorelbine—TUBB—lung—hematologic cancer	0.000175	0.0162	CbGeAlD
Vinorelbine—TUBB2B—testis—hematologic cancer	0.000175	0.0162	CbGeAlD
Vinorelbine—TUBB2A—lung—hematologic cancer	0.000174	0.0162	CbGeAlD
Vinorelbine—TUBB6—lung—hematologic cancer	0.000172	0.0159	CbGeAlD
Vinorelbine—TUBB4B—blood—hematologic cancer	0.00017	0.0158	CbGeAlD
Vinorelbine—Vinblastine—JUN—hematologic cancer	0.000166	0.191	CrCbGaD
Vinorelbine—TUBB—testis—hematologic cancer	0.000165	0.0153	CbGeAlD
Vinorelbine—TUBB4B—bone marrow—hematologic cancer	0.000165	0.0153	CbGeAlD
Vinorelbine—TUBB2A—testis—hematologic cancer	0.000164	0.0153	CbGeAlD
Vinorelbine—TUBB6—testis—hematologic cancer	0.000162	0.015	CbGeAlD
Vinorelbine—CYP3A4—Doxorubicin—hematologic cancer	0.00015	0.00104	CbGbCtD
Vinorelbine—TUBB4B—lung—hematologic cancer	0.000149	0.0139	CbGeAlD
Vinorelbine—TUBB4B—testis—hematologic cancer	0.000141	0.0131	CbGeAlD
Vinorelbine—TUBB4A—lymph node—hematologic cancer	0.000131	0.0122	CbGeAlD
Vinorelbine—TUBB2B—lymph node—hematologic cancer	0.000127	0.0117	CbGeAlD
Vinorelbine—TUBB—lymph node—hematologic cancer	0.00012	0.0111	CbGeAlD
Vinorelbine—TUBB2A—lymph node—hematologic cancer	0.000119	0.0111	CbGeAlD
Vinorelbine—TUBB6—lymph node—hematologic cancer	0.000117	0.0109	CbGeAlD
Vinorelbine—Vincristine—ABCC3—hematologic cancer	0.000113	0.13	CrCbGaD
Vinorelbine—CYP3A4—hematopoietic system—hematologic cancer	0.000106	0.0098	CbGeAlD
Vinorelbine—CYP2D6—hematopoietic system—hematologic cancer	0.000104	0.00965	CbGeAlD
Vinorelbine—TUBB4B—lymph node—hematologic cancer	0.000102	0.00948	CbGeAlD
Vinorelbine—TUBB—Menadione—Thalidomide—hematologic cancer	9.02e-05	0.127	CbGdCrCtD
Vinorelbine—ABCB1—hematopoietic system—hematologic cancer	7.48e-05	0.00694	CbGeAlD
Vinorelbine—TUBB6—Vitamin A—Alitretinoin—hematologic cancer	7.06e-05	0.099	CbGdCrCtD
Vinorelbine—CYP3A4—blood—hematologic cancer	7e-05	0.00649	CbGeAlD
Vinorelbine—CYP2D6—blood—hematologic cancer	6.88e-05	0.00639	CbGeAlD
Vinorelbine—Voacamine—ABCB1—hematologic cancer	6.53e-05	0.075	CrCbGaD
Vinorelbine—CYP2D6—testis—hematologic cancer	5.69e-05	0.00529	CbGeAlD
Vinorelbine—ABCB1—gonad—hematologic cancer	5.68e-05	0.00528	CbGeAlD
Vinorelbine—TUBB6—Zalcitabine—Gemcitabine—hematologic cancer	5.61e-05	0.0787	CbGdCrCtD
Vinorelbine—TUBB6—Zalcitabine—Cytarabine—hematologic cancer	5.61e-05	0.0787	CbGdCrCtD
Vinorelbine—Vincristine—ABCG2—hematologic cancer	5.5e-05	0.0632	CrCbGaD
Vinorelbine—ABCB1—blood—hematologic cancer	4.95e-05	0.0046	CbGeAlD
Vinorelbine—TUBB6—Tretinoin—Alitretinoin—hematologic cancer	4.93e-05	0.0692	CbGdCrCtD
Vinorelbine—TUBB6—Isotretinoin—Alitretinoin—hematologic cancer	4.93e-05	0.0692	CbGdCrCtD
Vinorelbine—ABCB1—bone marrow—hematologic cancer	4.79e-05	0.00445	CbGeAlD
Vinorelbine—TUBB—Azacitidine—Pentostatin—hematologic cancer	4.62e-05	0.0648	CbGdCrCtD
Vinorelbine—ABCB1—lung—hematologic cancer	4.34e-05	0.00403	CbGeAlD
Vinorelbine—TUBB—Azacitidine—Clofarabine—hematologic cancer	4.12e-05	0.0578	CbGdCrCtD
Vinorelbine—ABCB1—testis—hematologic cancer	4.1e-05	0.0038	CbGeAlD
Vinorelbine—TUBB—Azacitidine—Nelarabine—hematologic cancer	3.87e-05	0.0543	CbGdCrCtD
Vinorelbine—TUBB—Azacitidine—Fludarabine—hematologic cancer	3.02e-05	0.0424	CbGdCrCtD
Vinorelbine—ABCB1—lymph node—hematologic cancer	2.97e-05	0.00276	CbGeAlD
Vinorelbine—TUBB—Azacitidine—Gemcitabine—hematologic cancer	2.85e-05	0.0401	CbGdCrCtD
Vinorelbine—TUBB—Azacitidine—Cytarabine—hematologic cancer	2.85e-05	0.0401	CbGdCrCtD
Vinorelbine—TUBB—Azacitidine—Cladribine—hematologic cancer	2.78e-05	0.039	CbGdCrCtD
Vinorelbine—Vinblastine—ABCB1—hematologic cancer	2.33e-05	0.0268	CrCbGaD
Vinorelbine—Vincristine—ABCB1—hematologic cancer	2.29e-05	0.0263	CrCbGaD
Vinorelbine—TUBB6—Azacitidine—Pentostatin—hematologic cancer	1.91e-05	0.0268	CbGdCrCtD
Vinorelbine—TUBB6—Azacitidine—Clofarabine—hematologic cancer	1.7e-05	0.0239	CbGdCrCtD
Vinorelbine—TUBB6—Azacitidine—Nelarabine—hematologic cancer	1.6e-05	0.0224	CbGdCrCtD
Vinorelbine—TUBB6—Azacitidine—Fludarabine—hematologic cancer	1.25e-05	0.0175	CbGdCrCtD
Vinorelbine—TUBB6—Azacitidine—Cytarabine—hematologic cancer	1.18e-05	0.0165	CbGdCrCtD
Vinorelbine—TUBB6—Azacitidine—Gemcitabine—hematologic cancer	1.18e-05	0.0165	CbGdCrCtD
Vinorelbine—TUBB6—Azacitidine—Cladribine—hematologic cancer	1.15e-05	0.0161	CbGdCrCtD
Vinorelbine—Erythema—Methotrexate—hematologic cancer	3.83e-06	7.45e-05	CcSEcCtD
Vinorelbine—Malnutrition—Methotrexate—hematologic cancer	3.83e-06	7.45e-05	CcSEcCtD
Vinorelbine—Headache—Gemcitabine—hematologic cancer	3.82e-06	7.44e-05	CcSEcCtD
Vinorelbine—Nausea—Vincristine—hematologic cancer	3.82e-06	7.44e-05	CcSEcCtD
Vinorelbine—Cardiac disorder—Epirubicin—hematologic cancer	3.82e-06	7.43e-05	CcSEcCtD
Vinorelbine—Flushing—Epirubicin—hematologic cancer	3.82e-06	7.43e-05	CcSEcCtD
Vinorelbine—Hypersensitivity—Prednisolone—hematologic cancer	3.79e-06	7.37e-05	CcSEcCtD
Vinorelbine—Hypoaesthesia—Doxorubicin—hematologic cancer	3.79e-06	7.37e-05	CcSEcCtD
Vinorelbine—Urticaria—Triamcinolone—hematologic cancer	3.76e-06	7.31e-05	CcSEcCtD
Vinorelbine—Asthenia—Etoposide—hematologic cancer	3.74e-06	7.28e-05	CcSEcCtD
Vinorelbine—Connective tissue disorder—Doxorubicin—hematologic cancer	3.74e-06	7.28e-05	CcSEcCtD
Vinorelbine—Body temperature increased—Triamcinolone—hematologic cancer	3.74e-06	7.27e-05	CcSEcCtD
Vinorelbine—Anaphylactic shock—Prednisone—hematologic cancer	3.74e-06	7.27e-05	CcSEcCtD
Vinorelbine—Angiopathy—Epirubicin—hematologic cancer	3.73e-06	7.26e-05	CcSEcCtD
Vinorelbine—Decreased appetite—Dexamethasone—hematologic cancer	3.73e-06	7.26e-05	CcSEcCtD
Vinorelbine—Decreased appetite—Betamethasone—hematologic cancer	3.73e-06	7.26e-05	CcSEcCtD
Vinorelbine—Nausea—Mitoxantrone—hematologic cancer	3.72e-06	7.24e-05	CcSEcCtD
Vinorelbine—Nausea—Irinotecan—hematologic cancer	3.72e-06	7.24e-05	CcSEcCtD
Vinorelbine—Immune system disorder—Epirubicin—hematologic cancer	3.71e-06	7.23e-05	CcSEcCtD
Vinorelbine—Infection—Prednisone—hematologic cancer	3.71e-06	7.22e-05	CcSEcCtD
Vinorelbine—Mediastinal disorder—Epirubicin—hematologic cancer	3.71e-06	7.21e-05	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.7e-06	7.21e-05	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.7e-06	7.21e-05	CcSEcCtD
Vinorelbine—Back pain—Methotrexate—hematologic cancer	3.7e-06	7.2e-05	CcSEcCtD
Vinorelbine—Fatigue—Dexamethasone—hematologic cancer	3.7e-06	7.2e-05	CcSEcCtD
Vinorelbine—Fatigue—Betamethasone—hematologic cancer	3.7e-06	7.2e-05	CcSEcCtD
Vinorelbine—Pruritus—Etoposide—hematologic cancer	3.69e-06	7.18e-05	CcSEcCtD
Vinorelbine—Arrhythmia—Epirubicin—hematologic cancer	3.67e-06	7.15e-05	CcSEcCtD
Vinorelbine—Pain—Betamethasone—hematologic cancer	3.67e-06	7.14e-05	CcSEcCtD
Vinorelbine—Pain—Dexamethasone—hematologic cancer	3.67e-06	7.14e-05	CcSEcCtD
Vinorelbine—Nervous system disorder—Prednisone—hematologic cancer	3.66e-06	7.13e-05	CcSEcCtD
Vinorelbine—Tachycardia—Prednisone—hematologic cancer	3.65e-06	7.1e-05	CcSEcCtD
Vinorelbine—Alopecia—Epirubicin—hematologic cancer	3.63e-06	7.07e-05	CcSEcCtD
Vinorelbine—Skin disorder—Prednisone—hematologic cancer	3.63e-06	7.06e-05	CcSEcCtD
Vinorelbine—Nausea—Gemcitabine—hematologic cancer	3.63e-06	7.06e-05	CcSEcCtD
Vinorelbine—Vomiting—Cisplatin—hematologic cancer	3.62e-06	7.04e-05	CcSEcCtD
Vinorelbine—Rash—Cisplatin—hematologic cancer	3.59e-06	6.98e-05	CcSEcCtD
Vinorelbine—Dermatitis—Cisplatin—hematologic cancer	3.58e-06	6.98e-05	CcSEcCtD
Vinorelbine—Malnutrition—Epirubicin—hematologic cancer	3.58e-06	6.97e-05	CcSEcCtD
Vinorelbine—Erythema—Epirubicin—hematologic cancer	3.58e-06	6.97e-05	CcSEcCtD
Vinorelbine—Diarrhoea—Etoposide—hematologic cancer	3.57e-06	6.94e-05	CcSEcCtD
Vinorelbine—Anorexia—Prednisone—hematologic cancer	3.56e-06	6.93e-05	CcSEcCtD
Vinorelbine—Ill-defined disorder—Methotrexate—hematologic cancer	3.55e-06	6.91e-05	CcSEcCtD
Vinorelbine—Anaemia—Methotrexate—hematologic cancer	3.54e-06	6.88e-05	CcSEcCtD
Vinorelbine—Feeling abnormal—Dexamethasone—hematologic cancer	3.54e-06	6.88e-05	CcSEcCtD
Vinorelbine—Feeling abnormal—Betamethasone—hematologic cancer	3.54e-06	6.88e-05	CcSEcCtD
Vinorelbine—Cardiac disorder—Doxorubicin—hematologic cancer	3.53e-06	6.87e-05	CcSEcCtD
Vinorelbine—Flushing—Doxorubicin—hematologic cancer	3.53e-06	6.87e-05	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.51e-06	6.83e-05	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Betamethasone—hematologic cancer	3.51e-06	6.83e-05	CcSEcCtD
Vinorelbine—Hypersensitivity—Triamcinolone—hematologic cancer	3.48e-06	6.78e-05	CcSEcCtD
Vinorelbine—Back pain—Epirubicin—hematologic cancer	3.46e-06	6.74e-05	CcSEcCtD
Vinorelbine—Angiopathy—Doxorubicin—hematologic cancer	3.45e-06	6.72e-05	CcSEcCtD
Vinorelbine—Malaise—Methotrexate—hematologic cancer	3.45e-06	6.71e-05	CcSEcCtD
Vinorelbine—Dizziness—Etoposide—hematologic cancer	3.45e-06	6.71e-05	CcSEcCtD
Vinorelbine—Immune system disorder—Doxorubicin—hematologic cancer	3.44e-06	6.69e-05	CcSEcCtD
Vinorelbine—Vertigo—Methotrexate—hematologic cancer	3.44e-06	6.69e-05	CcSEcCtD
Vinorelbine—Mediastinal disorder—Doxorubicin—hematologic cancer	3.43e-06	6.67e-05	CcSEcCtD
Vinorelbine—Leukopenia—Methotrexate—hematologic cancer	3.42e-06	6.66e-05	CcSEcCtD
Vinorelbine—Urticaria—Dexamethasone—hematologic cancer	3.41e-06	6.63e-05	CcSEcCtD
Vinorelbine—Urticaria—Betamethasone—hematologic cancer	3.41e-06	6.63e-05	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.4e-06	6.62e-05	CcSEcCtD
Vinorelbine—Dizziness—Prednisolone—hematologic cancer	3.4e-06	6.62e-05	CcSEcCtD
Vinorelbine—Arrhythmia—Doxorubicin—hematologic cancer	3.4e-06	6.62e-05	CcSEcCtD
Vinorelbine—Asthenia—Triamcinolone—hematologic cancer	3.39e-06	6.6e-05	CcSEcCtD
Vinorelbine—Body temperature increased—Betamethasone—hematologic cancer	3.39e-06	6.6e-05	CcSEcCtD
Vinorelbine—Abdominal pain—Betamethasone—hematologic cancer	3.39e-06	6.6e-05	CcSEcCtD
Vinorelbine—Abdominal pain—Dexamethasone—hematologic cancer	3.39e-06	6.6e-05	CcSEcCtD
Vinorelbine—Body temperature increased—Dexamethasone—hematologic cancer	3.39e-06	6.6e-05	CcSEcCtD
Vinorelbine—Nausea—Cisplatin—hematologic cancer	3.38e-06	6.58e-05	CcSEcCtD
Vinorelbine—Alopecia—Doxorubicin—hematologic cancer	3.36e-06	6.54e-05	CcSEcCtD
Vinorelbine—Paraesthesia—Prednisone—hematologic cancer	3.35e-06	6.53e-05	CcSEcCtD
Vinorelbine—Pruritus—Triamcinolone—hematologic cancer	3.34e-06	6.51e-05	CcSEcCtD
Vinorelbine—Cough—Methotrexate—hematologic cancer	3.34e-06	6.5e-05	CcSEcCtD
Vinorelbine—Ill-defined disorder—Epirubicin—hematologic cancer	3.32e-06	6.46e-05	CcSEcCtD
Vinorelbine—Vomiting—Etoposide—hematologic cancer	3.31e-06	6.45e-05	CcSEcCtD
Vinorelbine—Erythema—Doxorubicin—hematologic cancer	3.31e-06	6.45e-05	CcSEcCtD
Vinorelbine—Malnutrition—Doxorubicin—hematologic cancer	3.31e-06	6.45e-05	CcSEcCtD
Vinorelbine—Anaemia—Epirubicin—hematologic cancer	3.31e-06	6.44e-05	CcSEcCtD
Vinorelbine—Rash—Etoposide—hematologic cancer	3.29e-06	6.4e-05	CcSEcCtD
Vinorelbine—Dermatitis—Etoposide—hematologic cancer	3.28e-06	6.39e-05	CcSEcCtD
Vinorelbine—Headache—Etoposide—hematologic cancer	3.27e-06	6.36e-05	CcSEcCtD
Vinorelbine—Chest pain—Methotrexate—hematologic cancer	3.26e-06	6.34e-05	CcSEcCtD
Vinorelbine—Myalgia—Methotrexate—hematologic cancer	3.26e-06	6.34e-05	CcSEcCtD
Vinorelbine—Arthralgia—Methotrexate—hematologic cancer	3.26e-06	6.34e-05	CcSEcCtD
Vinorelbine—Decreased appetite—Prednisone—hematologic cancer	3.25e-06	6.32e-05	CcSEcCtD
Vinorelbine—Rash—Prednisolone—hematologic cancer	3.24e-06	6.31e-05	CcSEcCtD
Vinorelbine—Dermatitis—Prednisolone—hematologic cancer	3.24e-06	6.3e-05	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.23e-06	6.29e-05	CcSEcCtD
Vinorelbine—Malaise—Epirubicin—hematologic cancer	3.23e-06	6.28e-05	CcSEcCtD
Vinorelbine—Fatigue—Prednisone—hematologic cancer	3.22e-06	6.27e-05	CcSEcCtD
Vinorelbine—Headache—Prednisolone—hematologic cancer	3.22e-06	6.27e-05	CcSEcCtD
Vinorelbine—Discomfort—Methotrexate—hematologic cancer	3.22e-06	6.26e-05	CcSEcCtD
Vinorelbine—Vertigo—Epirubicin—hematologic cancer	3.22e-06	6.26e-05	CcSEcCtD
Vinorelbine—Leukopenia—Epirubicin—hematologic cancer	3.2e-06	6.24e-05	CcSEcCtD
Vinorelbine—Back pain—Doxorubicin—hematologic cancer	3.2e-06	6.24e-05	CcSEcCtD
Vinorelbine—Constipation—Prednisone—hematologic cancer	3.19e-06	6.22e-05	CcSEcCtD
Vinorelbine—Palpitations—Epirubicin—hematologic cancer	3.16e-06	6.16e-05	CcSEcCtD
Vinorelbine—Dizziness—Triamcinolone—hematologic cancer	3.13e-06	6.08e-05	CcSEcCtD
Vinorelbine—Cough—Epirubicin—hematologic cancer	3.12e-06	6.08e-05	CcSEcCtD
Vinorelbine—Anaphylactic shock—Methotrexate—hematologic cancer	3.12e-06	6.08e-05	CcSEcCtD
Vinorelbine—Infection—Methotrexate—hematologic cancer	3.1e-06	6.04e-05	CcSEcCtD
Vinorelbine—Nausea—Etoposide—hematologic cancer	3.1e-06	6.03e-05	CcSEcCtD
Vinorelbine—Hypertension—Epirubicin—hematologic cancer	3.09e-06	6.02e-05	CcSEcCtD
Vinorelbine—Feeling abnormal—Prednisone—hematologic cancer	3.08e-06	5.99e-05	CcSEcCtD
Vinorelbine—Asthenia—Dexamethasone—hematologic cancer	3.08e-06	5.99e-05	CcSEcCtD
Vinorelbine—Asthenia—Betamethasone—hematologic cancer	3.08e-06	5.99e-05	CcSEcCtD
Vinorelbine—Ill-defined disorder—Doxorubicin—hematologic cancer	3.07e-06	5.98e-05	CcSEcCtD
Vinorelbine—Nervous system disorder—Methotrexate—hematologic cancer	3.06e-06	5.96e-05	CcSEcCtD
Vinorelbine—Anaemia—Doxorubicin—hematologic cancer	3.06e-06	5.96e-05	CcSEcCtD
Vinorelbine—Thrombocytopenia—Methotrexate—hematologic cancer	3.06e-06	5.95e-05	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Prednisone—hematologic cancer	3.05e-06	5.95e-05	CcSEcCtD
Vinorelbine—Nausea—Prednisolone—hematologic cancer	3.05e-06	5.94e-05	CcSEcCtD
Vinorelbine—Chest pain—Epirubicin—hematologic cancer	3.05e-06	5.93e-05	CcSEcCtD
Vinorelbine—Myalgia—Epirubicin—hematologic cancer	3.05e-06	5.93e-05	CcSEcCtD
Vinorelbine—Arthralgia—Epirubicin—hematologic cancer	3.05e-06	5.93e-05	CcSEcCtD
Vinorelbine—Pruritus—Betamethasone—hematologic cancer	3.03e-06	5.91e-05	CcSEcCtD
Vinorelbine—Pruritus—Dexamethasone—hematologic cancer	3.03e-06	5.91e-05	CcSEcCtD
Vinorelbine—Skin disorder—Methotrexate—hematologic cancer	3.03e-06	5.9e-05	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.03e-06	5.89e-05	CcSEcCtD
Vinorelbine—Discomfort—Epirubicin—hematologic cancer	3.01e-06	5.86e-05	CcSEcCtD
Vinorelbine—Vomiting—Triamcinolone—hematologic cancer	3.01e-06	5.85e-05	CcSEcCtD
Vinorelbine—Malaise—Doxorubicin—hematologic cancer	2.99e-06	5.81e-05	CcSEcCtD
Vinorelbine—Rash—Triamcinolone—hematologic cancer	2.98e-06	5.8e-05	CcSEcCtD
Vinorelbine—Dermatitis—Triamcinolone—hematologic cancer	2.98e-06	5.8e-05	CcSEcCtD
Vinorelbine—Vertigo—Doxorubicin—hematologic cancer	2.98e-06	5.79e-05	CcSEcCtD
Vinorelbine—Anorexia—Methotrexate—hematologic cancer	2.98e-06	5.79e-05	CcSEcCtD
Vinorelbine—Urticaria—Prednisone—hematologic cancer	2.97e-06	5.78e-05	CcSEcCtD
Vinorelbine—Leukopenia—Doxorubicin—hematologic cancer	2.97e-06	5.77e-05	CcSEcCtD
Vinorelbine—Headache—Triamcinolone—hematologic cancer	2.96e-06	5.76e-05	CcSEcCtD
Vinorelbine—Body temperature increased—Prednisone—hematologic cancer	2.95e-06	5.75e-05	CcSEcCtD
Vinorelbine—Abdominal pain—Prednisone—hematologic cancer	2.95e-06	5.75e-05	CcSEcCtD
Vinorelbine—Diarrhoea—Betamethasone—hematologic cancer	2.94e-06	5.71e-05	CcSEcCtD
Vinorelbine—Diarrhoea—Dexamethasone—hematologic cancer	2.94e-06	5.71e-05	CcSEcCtD
Vinorelbine—Palpitations—Doxorubicin—hematologic cancer	2.93e-06	5.7e-05	CcSEcCtD
Vinorelbine—Anaphylactic shock—Epirubicin—hematologic cancer	2.92e-06	5.69e-05	CcSEcCtD
Vinorelbine—Hypotension—Methotrexate—hematologic cancer	2.92e-06	5.68e-05	CcSEcCtD
Vinorelbine—Infection—Epirubicin—hematologic cancer	2.9e-06	5.65e-05	CcSEcCtD
Vinorelbine—Cough—Doxorubicin—hematologic cancer	2.89e-06	5.63e-05	CcSEcCtD
Vinorelbine—Nervous system disorder—Epirubicin—hematologic cancer	2.87e-06	5.58e-05	CcSEcCtD
Vinorelbine—Thrombocytopenia—Epirubicin—hematologic cancer	2.86e-06	5.57e-05	CcSEcCtD
Vinorelbine—Hypertension—Doxorubicin—hematologic cancer	2.86e-06	5.57e-05	CcSEcCtD
Vinorelbine—Tachycardia—Epirubicin—hematologic cancer	2.85e-06	5.55e-05	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.84e-06	5.54e-05	CcSEcCtD
Vinorelbine—Skin disorder—Epirubicin—hematologic cancer	2.84e-06	5.52e-05	CcSEcCtD
Vinorelbine—Dizziness—Betamethasone—hematologic cancer	2.84e-06	5.52e-05	CcSEcCtD
Vinorelbine—Dizziness—Dexamethasone—hematologic cancer	2.84e-06	5.52e-05	CcSEcCtD
Vinorelbine—Chest pain—Doxorubicin—hematologic cancer	2.82e-06	5.49e-05	CcSEcCtD
Vinorelbine—Arthralgia—Doxorubicin—hematologic cancer	2.82e-06	5.49e-05	CcSEcCtD
Vinorelbine—Myalgia—Doxorubicin—hematologic cancer	2.82e-06	5.49e-05	CcSEcCtD
Vinorelbine—Nausea—Triamcinolone—hematologic cancer	2.81e-06	5.47e-05	CcSEcCtD
Vinorelbine—Paraesthesia—Methotrexate—hematologic cancer	2.8e-06	5.46e-05	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.8e-06	5.45e-05	CcSEcCtD
Vinorelbine—Discomfort—Doxorubicin—hematologic cancer	2.79e-06	5.42e-05	CcSEcCtD
Vinorelbine—Anorexia—Epirubicin—hematologic cancer	2.79e-06	5.42e-05	CcSEcCtD
Vinorelbine—Dyspnoea—Methotrexate—hematologic cancer	2.78e-06	5.42e-05	CcSEcCtD
Vinorelbine—Hypersensitivity—Prednisone—hematologic cancer	2.75e-06	5.36e-05	CcSEcCtD
Vinorelbine—Hypotension—Epirubicin—hematologic cancer	2.73e-06	5.31e-05	CcSEcCtD
Vinorelbine—Vomiting—Dexamethasone—hematologic cancer	2.73e-06	5.31e-05	CcSEcCtD
Vinorelbine—Vomiting—Betamethasone—hematologic cancer	2.73e-06	5.31e-05	CcSEcCtD
Vinorelbine—Decreased appetite—Methotrexate—hematologic cancer	2.71e-06	5.28e-05	CcSEcCtD
Vinorelbine—Rash—Dexamethasone—hematologic cancer	2.7e-06	5.26e-05	CcSEcCtD
Vinorelbine—Rash—Betamethasone—hematologic cancer	2.7e-06	5.26e-05	CcSEcCtD
Vinorelbine—Anaphylactic shock—Doxorubicin—hematologic cancer	2.7e-06	5.26e-05	CcSEcCtD
Vinorelbine—Dermatitis—Dexamethasone—hematologic cancer	2.7e-06	5.26e-05	CcSEcCtD
Vinorelbine—Dermatitis—Betamethasone—hematologic cancer	2.7e-06	5.26e-05	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.7e-06	5.25e-05	CcSEcCtD
Vinorelbine—Fatigue—Methotrexate—hematologic cancer	2.69e-06	5.24e-05	CcSEcCtD
Vinorelbine—Headache—Betamethasone—hematologic cancer	2.69e-06	5.23e-05	CcSEcCtD
Vinorelbine—Headache—Dexamethasone—hematologic cancer	2.69e-06	5.23e-05	CcSEcCtD
Vinorelbine—Infection—Doxorubicin—hematologic cancer	2.69e-06	5.23e-05	CcSEcCtD
Vinorelbine—Asthenia—Prednisone—hematologic cancer	2.68e-06	5.22e-05	CcSEcCtD
Vinorelbine—Pain—Methotrexate—hematologic cancer	2.67e-06	5.2e-05	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.66e-06	5.18e-05	CcSEcCtD
Vinorelbine—Nervous system disorder—Doxorubicin—hematologic cancer	2.65e-06	5.16e-05	CcSEcCtD
Vinorelbine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.65e-06	5.15e-05	CcSEcCtD
Vinorelbine—Pruritus—Prednisone—hematologic cancer	2.64e-06	5.14e-05	CcSEcCtD
Vinorelbine—Tachycardia—Doxorubicin—hematologic cancer	2.64e-06	5.14e-05	CcSEcCtD
Vinorelbine—Skin disorder—Doxorubicin—hematologic cancer	2.63e-06	5.11e-05	CcSEcCtD
Vinorelbine—Paraesthesia—Epirubicin—hematologic cancer	2.62e-06	5.11e-05	CcSEcCtD
Vinorelbine—Dyspnoea—Epirubicin—hematologic cancer	2.6e-06	5.07e-05	CcSEcCtD
Vinorelbine—Anorexia—Doxorubicin—hematologic cancer	2.58e-06	5.02e-05	CcSEcCtD
Vinorelbine—Feeling abnormal—Methotrexate—hematologic cancer	2.57e-06	5.01e-05	CcSEcCtD
Vinorelbine—Diarrhoea—Prednisone—hematologic cancer	2.56e-06	4.97e-05	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.55e-06	4.97e-05	CcSEcCtD
Vinorelbine—Nausea—Betamethasone—hematologic cancer	2.55e-06	4.96e-05	CcSEcCtD
Vinorelbine—Nausea—Dexamethasone—hematologic cancer	2.55e-06	4.96e-05	CcSEcCtD
Vinorelbine—Decreased appetite—Epirubicin—hematologic cancer	2.54e-06	4.94e-05	CcSEcCtD
Vinorelbine—Hypotension—Doxorubicin—hematologic cancer	2.53e-06	4.92e-05	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.52e-06	4.91e-05	CcSEcCtD
Vinorelbine—Fatigue—Epirubicin—hematologic cancer	2.52e-06	4.9e-05	CcSEcCtD
Vinorelbine—Constipation—Epirubicin—hematologic cancer	2.5e-06	4.86e-05	CcSEcCtD
Vinorelbine—Pain—Epirubicin—hematologic cancer	2.5e-06	4.86e-05	CcSEcCtD
Vinorelbine—Urticaria—Methotrexate—hematologic cancer	2.48e-06	4.83e-05	CcSEcCtD
Vinorelbine—Dizziness—Prednisone—hematologic cancer	2.47e-06	4.81e-05	CcSEcCtD
Vinorelbine—Abdominal pain—Methotrexate—hematologic cancer	2.47e-06	4.8e-05	CcSEcCtD
Vinorelbine—Body temperature increased—Methotrexate—hematologic cancer	2.47e-06	4.8e-05	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.46e-06	4.79e-05	CcSEcCtD
Vinorelbine—Paraesthesia—Doxorubicin—hematologic cancer	2.43e-06	4.72e-05	CcSEcCtD
Vinorelbine—Dyspnoea—Doxorubicin—hematologic cancer	2.41e-06	4.69e-05	CcSEcCtD
Vinorelbine—Feeling abnormal—Epirubicin—hematologic cancer	2.41e-06	4.69e-05	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Epirubicin—hematologic cancer	2.39e-06	4.65e-05	CcSEcCtD
Vinorelbine—Vomiting—Prednisone—hematologic cancer	2.38e-06	4.62e-05	CcSEcCtD
Vinorelbine—Rash—Prednisone—hematologic cancer	2.36e-06	4.58e-05	CcSEcCtD
Vinorelbine—Dermatitis—Prednisone—hematologic cancer	2.35e-06	4.58e-05	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—CDKN2A—hematologic cancer	2.35e-06	0.000109	CbGpPWpGaD
Vinorelbine—Decreased appetite—Doxorubicin—hematologic cancer	2.35e-06	4.57e-05	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	2.35e-06	0.000109	CbGpPWpGaD
Vinorelbine—Headache—Prednisone—hematologic cancer	2.34e-06	4.55e-05	CcSEcCtD
Vinorelbine—CYP2D6—Metabolism—GMPS—hematologic cancer	2.34e-06	0.000109	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PHYH—hematologic cancer	2.34e-06	0.000109	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—FTCD—hematologic cancer	2.34e-06	0.000109	CbGpPWpGaD
Vinorelbine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.33e-06	4.54e-05	CcSEcCtD
Vinorelbine—Fatigue—Doxorubicin—hematologic cancer	2.33e-06	4.54e-05	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	2.33e-06	0.000108	CbGpPWpGaD
Vinorelbine—Urticaria—Epirubicin—hematologic cancer	2.32e-06	4.52e-05	CcSEcCtD
Vinorelbine—Constipation—Doxorubicin—hematologic cancer	2.31e-06	4.5e-05	CcSEcCtD
Vinorelbine—Pain—Doxorubicin—hematologic cancer	2.31e-06	4.5e-05	CcSEcCtD
Vinorelbine—Abdominal pain—Epirubicin—hematologic cancer	2.31e-06	4.5e-05	CcSEcCtD
Vinorelbine—Body temperature increased—Epirubicin—hematologic cancer	2.31e-06	4.5e-05	CcSEcCtD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—ALB—hematologic cancer	2.3e-06	0.000107	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Methotrexate—hematologic cancer	2.3e-06	4.48e-05	CcSEcCtD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	2.28e-06	0.000106	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MDM2—hematologic cancer	2.28e-06	0.000106	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN1B—hematologic cancer	2.28e-06	0.000106	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SMPD3—hematologic cancer	2.27e-06	0.000106	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	2.26e-06	0.000105	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CCL2—hematologic cancer	2.25e-06	0.000104	CbGpPWpGaD
Vinorelbine—Asthenia—Methotrexate—hematologic cancer	2.24e-06	4.36e-05	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—EP300—hematologic cancer	2.24e-06	0.000104	CbGpPWpGaD
Vinorelbine—Feeling abnormal—Doxorubicin—hematologic cancer	2.23e-06	4.34e-05	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCND1—hematologic cancer	2.22e-06	0.000103	CbGpPWpGaD
Vinorelbine—Nausea—Prednisone—hematologic cancer	2.22e-06	4.32e-05	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.21e-06	4.3e-05	CcSEcCtD
Vinorelbine—Pruritus—Methotrexate—hematologic cancer	2.21e-06	4.3e-05	CcSEcCtD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	2.2e-06	0.000102	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	2.19e-06	0.000102	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CCND1—hematologic cancer	2.17e-06	0.000101	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	2.17e-06	0.000101	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MAPK3—hematologic cancer	2.16e-06	0.0001	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	2.16e-06	0.0001	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Epirubicin—hematologic cancer	2.15e-06	4.19e-05	CcSEcCtD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	2.15e-06	9.99e-05	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	2.15e-06	9.99e-05	CbGpPWpGaD
Vinorelbine—Urticaria—Doxorubicin—hematologic cancer	2.15e-06	4.18e-05	CcSEcCtD
Vinorelbine—CYP2D6—Metabolism—SMPD3—hematologic cancer	2.14e-06	9.94e-05	CbGpPWpGaD
Vinorelbine—Body temperature increased—Doxorubicin—hematologic cancer	2.14e-06	4.16e-05	CcSEcCtD
Vinorelbine—Abdominal pain—Doxorubicin—hematologic cancer	2.14e-06	4.16e-05	CcSEcCtD
Vinorelbine—Diarrhoea—Methotrexate—hematologic cancer	2.14e-06	4.16e-05	CcSEcCtD
Vinorelbine—ABCB1—Allograft Rejection—TNF—hematologic cancer	2.11e-06	9.81e-05	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MYC—hematologic cancer	2.1e-06	9.77e-05	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN1A—hematologic cancer	2.1e-06	9.76e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	2.1e-06	9.75e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	2.1e-06	9.75e-05	CbGpPWpGaD
Vinorelbine—Asthenia—Epirubicin—hematologic cancer	2.1e-06	4.08e-05	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—CDKN1B—hematologic cancer	2.08e-06	9.68e-05	CbGpPWpGaD
Vinorelbine—Pruritus—Epirubicin—hematologic cancer	2.07e-06	4.02e-05	CcSEcCtD
Vinorelbine—Dizziness—Methotrexate—hematologic cancer	2.06e-06	4.02e-05	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—EP300—hematologic cancer	2.04e-06	9.5e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	2.01e-06	9.35e-05	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MAPK3—hematologic cancer	2e-06	9.31e-05	CbGpPWpGaD
Vinorelbine—Diarrhoea—Epirubicin—hematologic cancer	2e-06	3.89e-05	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—EP300—hematologic cancer	2e-06	9.29e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	2e-06	9.28e-05	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Doxorubicin—hematologic cancer	1.99e-06	3.88e-05	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—CCND1—hematologic cancer	1.99e-06	9.23e-05	CbGpPWpGaD
Vinorelbine—Vomiting—Methotrexate—hematologic cancer	1.99e-06	3.86e-05	CcSEcCtD
Vinorelbine—ABCB1—Metabolism—B3GAT1—hematologic cancer	1.98e-06	9.22e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ASNS—hematologic cancer	1.98e-06	9.22e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—DCK—hematologic cancer	1.98e-06	9.22e-05	CbGpPWpGaD
Vinorelbine—Rash—Methotrexate—hematologic cancer	1.97e-06	3.83e-05	CcSEcCtD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.97e-06	9.15e-05	CbGpPWpGaD
Vinorelbine—Dermatitis—Methotrexate—hematologic cancer	1.97e-06	3.83e-05	CcSEcCtD
Vinorelbine—Headache—Methotrexate—hematologic cancer	1.96e-06	3.81e-05	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MYC—hematologic cancer	1.95e-06	9.05e-05	CbGpPWpGaD
Vinorelbine—Asthenia—Doxorubicin—hematologic cancer	1.94e-06	3.78e-05	CcSEcCtD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	1.93e-06	8.99e-05	CbGpPWpGaD
Vinorelbine—Dizziness—Epirubicin—hematologic cancer	1.93e-06	3.76e-05	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—CDKN1A—hematologic cancer	1.92e-06	8.93e-05	CbGpPWpGaD
Vinorelbine—Pruritus—Doxorubicin—hematologic cancer	1.91e-06	3.72e-05	CcSEcCtD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.9e-06	8.83e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	1.89e-06	8.8e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	1.88e-06	8.76e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HDC—hematologic cancer	1.88e-06	8.74e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ASNS—hematologic cancer	1.87e-06	8.69e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—DCK—hematologic cancer	1.87e-06	8.69e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—B3GAT1—hematologic cancer	1.87e-06	8.69e-05	CbGpPWpGaD
Vinorelbine—Vomiting—Epirubicin—hematologic cancer	1.86e-06	3.62e-05	CcSEcCtD
Vinorelbine—Nausea—Methotrexate—hematologic cancer	1.85e-06	3.61e-05	CcSEcCtD
Vinorelbine—Diarrhoea—Doxorubicin—hematologic cancer	1.85e-06	3.6e-05	CcSEcCtD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.84e-06	8.57e-05	CbGpPWpGaD
Vinorelbine—Rash—Epirubicin—hematologic cancer	1.84e-06	3.59e-05	CcSEcCtD
Vinorelbine—Dermatitis—Epirubicin—hematologic cancer	1.84e-06	3.58e-05	CcSEcCtD
Vinorelbine—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.83e-06	8.52e-05	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MAPK3—hematologic cancer	1.83e-06	8.51e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.83e-06	8.51e-05	CbGpPWpGaD
Vinorelbine—Headache—Epirubicin—hematologic cancer	1.83e-06	3.56e-05	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—EP300—hematologic cancer	1.83e-06	8.5e-05	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	1.81e-06	8.43e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.81e-06	8.41e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	1.8e-06	8.36e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.79e-06	8.34e-05	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MAPK3—hematologic cancer	1.79e-06	8.32e-05	CbGpPWpGaD
Vinorelbine—Dizziness—Doxorubicin—hematologic cancer	1.79e-06	3.48e-05	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MYC—hematologic cancer	1.78e-06	8.28e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HDC—hematologic cancer	1.77e-06	8.24e-05	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MYC—hematologic cancer	1.74e-06	8.1e-05	CbGpPWpGaD
Vinorelbine—Nausea—Epirubicin—hematologic cancer	1.74e-06	3.38e-05	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—TP53—hematologic cancer	1.73e-06	8.02e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CDA—hematologic cancer	1.72e-06	8e-05	CbGpPWpGaD
Vinorelbine—Vomiting—Doxorubicin—hematologic cancer	1.72e-06	3.35e-05	CcSEcCtD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.71e-06	7.95e-05	CbGpPWpGaD
Vinorelbine—Rash—Doxorubicin—hematologic cancer	1.7e-06	3.32e-05	CcSEcCtD
Vinorelbine—Dermatitis—Doxorubicin—hematologic cancer	1.7e-06	3.31e-05	CcSEcCtD
Vinorelbine—Headache—Doxorubicin—hematologic cancer	1.69e-06	3.3e-05	CcSEcCtD
Vinorelbine—ABCB1—Metabolism—PC—hematologic cancer	1.66e-06	7.7e-05	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MAPK3—hematologic cancer	1.64e-06	7.61e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.62e-06	7.55e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CDA—hematologic cancer	1.62e-06	7.53e-05	CbGpPWpGaD
Vinorelbine—Nausea—Doxorubicin—hematologic cancer	1.61e-06	3.13e-05	CcSEcCtD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.6e-06	7.44e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC35B2—hematologic cancer	1.6e-06	7.43e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GBA—hematologic cancer	1.6e-06	7.43e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.6e-06	7.43e-05	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MYC—hematologic cancer	1.59e-06	7.4e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PC—hematologic cancer	1.56e-06	7.25e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PHYH—hematologic cancer	1.53e-06	7.11e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—FTCD—hematologic cancer	1.53e-06	7.11e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GMPS—hematologic cancer	1.53e-06	7.11e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC35B2—hematologic cancer	1.51e-06	7e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GBA—hematologic cancer	1.51e-06	7e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—MTAP—hematologic cancer	1.46e-06	6.8e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.46e-06	6.79e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.43e-06	6.66e-05	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TP53—hematologic cancer	1.43e-06	6.65e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.4e-06	6.5e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.39e-06	6.48e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.39e-06	6.47e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—MTAP—hematologic cancer	1.38e-06	6.41e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.35e-06	6.27e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.35e-06	6.25e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.34e-06	6.24e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.32e-06	6.12e-05	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TP53—hematologic cancer	1.31e-06	6.08e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—FHL2—hematologic cancer	1.3e-06	6.06e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.28e-06	5.96e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AGRN—hematologic cancer	1.28e-06	5.94e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.25e-06	5.8e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—FHL2—hematologic cancer	1.23e-06	5.71e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.22e-06	5.68e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ASNS—hematologic cancer	1.22e-06	5.68e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—DCK—hematologic cancer	1.22e-06	5.68e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.22e-06	5.65e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HMMR—hematologic cancer	1.21e-06	5.63e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—IDH2—hematologic cancer	1.21e-06	5.63e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AGRN—hematologic cancer	1.21e-06	5.6e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HDC—hematologic cancer	1.16e-06	5.39e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.15e-06	5.34e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—IDH2—hematologic cancer	1.14e-06	5.31e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HMMR—hematologic cancer	1.14e-06	5.31e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ARNTL—hematologic cancer	1.14e-06	5.3e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.12e-06	5.2e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.12e-06	5.19e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ACP5—hematologic cancer	1.11e-06	5.15e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CA9—hematologic cancer	1.11e-06	5.15e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NCOR2—hematologic cancer	1.09e-06	5.09e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ARNTL—hematologic cancer	1.07e-06	4.99e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CDA—hematologic cancer	1.06e-06	4.93e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CA9—hematologic cancer	1.04e-06	4.86e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ACP5—hematologic cancer	1.04e-06	4.86e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—IDH1—hematologic cancer	1.04e-06	4.84e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.04e-06	4.84e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.03e-06	4.8e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NCOR2—hematologic cancer	1.03e-06	4.79e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ABCC3—hematologic cancer	1.03e-06	4.79e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTO1—hematologic cancer	1.03e-06	4.79e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TXN—hematologic cancer	1.03e-06	4.79e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PC—hematologic cancer	1.02e-06	4.74e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SPHK1—hematologic cancer	1.01e-06	4.69e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GBA—hematologic cancer	9.86e-07	4.58e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	9.86e-07	4.58e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—IDH1—hematologic cancer	9.82e-07	4.57e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ABCC3—hematologic cancer	9.71e-07	4.51e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTO1—hematologic cancer	9.71e-07	4.51e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TXN—hematologic cancer	9.71e-07	4.51e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—UGT1A1—hematologic cancer	9.69e-07	4.5e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SPHK1—hematologic cancer	9.51e-07	4.42e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	9.49e-07	4.41e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC22A1—hematologic cancer	9.43e-07	4.38e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CRABP1—hematologic cancer	9.43e-07	4.38e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALOX5—hematologic cancer	9.19e-07	4.27e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	9.19e-07	4.27e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	9.13e-07	4.24e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MTAP—hematologic cancer	9.01e-07	4.19e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NUP98—hematologic cancer	8.9e-07	4.13e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CRABP1—hematologic cancer	8.88e-07	4.13e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	8.88e-07	4.13e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALOX5—hematologic cancer	8.66e-07	4.02e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ADCY7—hematologic cancer	8.64e-07	4.01e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NCOA3—hematologic cancer	8.64e-07	4.01e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NUP214—hematologic cancer	8.58e-07	3.99e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—MTR—hematologic cancer	8.4e-07	3.9e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ABCG2—hematologic cancer	8.4e-07	3.9e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NUP98—hematologic cancer	8.38e-07	3.9e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ENO2—hematologic cancer	8.24e-07	3.83e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ADCY7—hematologic cancer	8.14e-07	3.78e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NCOA3—hematologic cancer	8.14e-07	3.78e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NUP214—hematologic cancer	8.08e-07	3.76e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—FHL2—hematologic cancer	8.03e-07	3.73e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTT1—hematologic cancer	7.99e-07	3.71e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ABCG2—hematologic cancer	7.92e-07	3.68e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—MTR—hematologic cancer	7.92e-07	3.68e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AGRN—hematologic cancer	7.88e-07	3.66e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SDC1—hematologic cancer	7.81e-07	3.63e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ENO2—hematologic cancer	7.77e-07	3.61e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	7.76e-07	3.6e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTT1—hematologic cancer	7.53e-07	3.5e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.48e-07	3.48e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HMMR—hematologic cancer	7.47e-07	3.47e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—IDH2—hematologic cancer	7.47e-07	3.47e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SDC1—hematologic cancer	7.36e-07	3.42e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ARNTL—hematologic cancer	7.02e-07	3.26e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	7e-07	3.25e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CA9—hematologic cancer	6.83e-07	3.17e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ACP5—hematologic cancer	6.83e-07	3.17e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NCOR2—hematologic cancer	6.74e-07	3.13e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NQO1—hematologic cancer	6.64e-07	3.09e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CD44—hematologic cancer	6.64e-07	3.09e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—IDH1—hematologic cancer	6.42e-07	2.98e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ABCC3—hematologic cancer	6.35e-07	2.95e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTO1—hematologic cancer	6.35e-07	2.95e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TXN—hematologic cancer	6.35e-07	2.95e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYCS—hematologic cancer	6.29e-07	2.92e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CD44—hematologic cancer	6.26e-07	2.91e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NQO1—hematologic cancer	6.26e-07	2.91e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	6.24e-07	2.9e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SPHK1—hematologic cancer	6.21e-07	2.89e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.97e-07	2.77e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYCS—hematologic cancer	5.92e-07	2.75e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.88e-07	2.73e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.81e-07	2.7e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.81e-07	2.7e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.66e-07	2.63e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTP1—hematologic cancer	5.54e-07	2.57e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NUP98—hematologic cancer	5.48e-07	2.55e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ADCY7—hematologic cancer	5.32e-07	2.47e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NCOA3—hematologic cancer	5.32e-07	2.47e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NUP214—hematologic cancer	5.28e-07	2.46e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTP1—hematologic cancer	5.22e-07	2.43e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MTR—hematologic cancer	5.18e-07	2.41e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.18e-07	2.41e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NCOR1—hematologic cancer	5.09e-07	2.37e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTM1—hematologic cancer	5.09e-07	2.37e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ENO2—hematologic cancer	5.08e-07	2.36e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.94e-07	2.3e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.92e-07	2.29e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SDC1—hematologic cancer	4.81e-07	2.24e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.8e-07	2.23e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.8e-07	2.23e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—MTHFR—hematologic cancer	4.5e-07	2.09e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—MTHFR—hematologic cancer	4.24e-07	1.97e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CD44—hematologic cancer	4.09e-07	1.9e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NQO1—hematologic cancer	4.09e-07	1.9e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYCS—hematologic cancer	3.87e-07	1.8e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.85e-07	1.79e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.78e-07	1.76e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.56e-07	1.66e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CREBBP—hematologic cancer	3.5e-07	1.63e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.41e-07	1.59e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CD—hematologic cancer	3.32e-07	1.54e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.3e-07	1.53e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALB—hematologic cancer	3.28e-07	1.52e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.23e-07	1.5e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3R1—hematologic cancer	3.14e-07	1.46e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.14e-07	1.46e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.14e-07	1.46e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	3.13e-07	1.46e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALB—hematologic cancer	3.09e-07	1.44e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.96e-07	1.37e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.9e-07	1.35e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.77e-07	1.29e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.73e-07	1.27e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTEN—hematologic cancer	2.5e-07	1.16e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—EP300—hematologic cancer	2.39e-07	1.11e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTEN—hematologic cancer	2.36e-07	1.1e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.33e-07	1.08e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—EP300—hematologic cancer	2.25e-07	1.05e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.16e-07	1e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.05e-07	9.51e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALB—hematologic cancer	2.02e-07	9.39e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.93e-07	8.98e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.78e-07	8.29e-06	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.77e-07	8.21e-06	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.66e-07	7.73e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.54e-07	7.17e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—EP300—hematologic cancer	1.47e-07	6.83e-06	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AKT1—hematologic cancer	1.44e-07	6.7e-06	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.36e-07	6.32e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.09e-07	5.06e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AKT1—hematologic cancer	8.89e-08	4.13e-06	CbGpPWpGaD
